PositiveDouble Blind Clinical Trial2018
Sativex® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
Classification Results
AI Classification
PositiveFine-tuned Classification
Positive